VolitionRx Limited Derivative Liability
VolitionRx Limited (VNRX) had Derivative Liability of $2.17 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities
us-gaap:DerivativeLiabilities · last filed 2026-08-13
- 2026-06-30: Derivative Liability $2.17M.
- 2026-03-31: Derivative Liability $876.76K.
- 2025-12-31: Derivative Liability $934.72K.
- 2025-09-30: Derivative Liability $319.35K.
| Period end | Derivative Liability |
|---|---|
| 2026-06-30 | $2.17M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $876.76K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $934.72K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $319.35K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $623.79K 10-Q · filed 2025-08-14 |
| 2024-12-31 | $0.00 10-Q · filed 2025-11-13 |
| 2014-12-31 | $1.58M 10-K · filed 2016-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |